Skip to content

Drug interactions

Mitotane + Pazopanib

Severity: Major

Mitotane and Pazopanib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mitotane is a strong CYP3A4 inducer with effects persisting for weeks after stopping. It can substantially reduce pazopanib concentrations and compromise efficacy.

What this interaction means in plain words

Mitotane and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Mitotane belongs to Oncology; Pazopanib belongs to Oncology.

Evidence level: Moderate

Why it happens

Mitotane induces CYP3A4, increasing pazopanib clearance.

What to do

Avoid concurrent use where possible; if unavoidable, monitor tumor response closely since dose escalation is not well established.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mitotane and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Mitotane with Pazopanib?

MediHelp rates the interaction as major. Mitotane and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mitotane is a strong CYP3A4 inducer with effects persisting for weeks after stopping. It can substantially reduce pazopanib concentrations and compromise efficacy.

How serious is the interaction between Mitotane and Pazopanib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible; if unavoidable, monitor tumor response closely since dose escalation is not well established.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in